Výsledky vyhledávání - "Krishna Athota"

Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial

Autor: Megan Webb, Devin Wakefield, Carolyn Philpott, Krishna Athota, Bryce H R Robinson, Molly E. Droege, Christopher A. Droege, Dennis J. Hanseman, Joel Elterman, Eric W. Mueller, Dina Gomaa, Joseph Richard Dowd, Neil Ernst

Publikováno v: Journal of Thrombosis and Thrombolysis. 52:1117-1128

The impact of antithrombin III activity (AT-III) on prophylactic enoxaparin anti-factor Xa concentration (anti-Xa) is unknown in high-risk trauma patients. So too is the optimal anti-Xa-adjusted enoxaparin dosage. This prospective, randomized, pilot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b36889cf1e87a68156d70579b72eb42a
https://doi.org/10.1007/s11239-021-02478-4

Zobrazit plný text záznamu

Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study

Autor: Christopher A. Droege, Krishna Athota, Joshua D Courter, Neil Ernst, Carolyn Philpott, Jessica Winter, Madeline Foertsch, Suzanne Van Fleet, Eric W. Mueller, Daniel P. Healy, Nicole Harger, Molly E. Droege, Kristen Carter

Publikováno v: PharmacotherapyReferences. 39(11)

Study objective To evaluate extended-infusion (EI) cefepime pharmacokinetics (PK) and pharmacodynamic target attainment in critically ill patients receiving continuous venovenous hemofiltration (CVVH) or continuous venovenous hemodialysis (CVVHD). De

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2639bfe39dce395e39e7227639be2e38
https://pubmed.ncbi.nlm.nih.gov/33112457

Zobrazit plný text záznamu

Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction

Autor: Peter M. Corry, Jason Moy, B S Diane Schoenherr, Alberto J. Crottogini, Cindy L. Grines, R T Ralph Gentry, Gilbert L. Raff, Michael J. Borrelli, Charles J. Shanley, William W. O'Neill, Krishna Athota, Laxmi S. Mehta, Judith Boura, Rubén P. Laguens, Mayra Guerrero

Publikováno v: Journal of interventional cardiology. 21(3)

Background: Vascular endothelial growth factor (VEGF)-165 promotes cardiomyogenesis in chronic myocardial ischemia and nonreperfused myocardial infarction (MI). It is unknown whether this effect is present in reperfused MI. We sought to investigate t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a348e5fd01923d5c6c23181277c25148
https://pubmed.ncbi.nlm.nih.gov/18422517

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání